Rani Therapeutics Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Rani Therapeutics Inc. | RANI - NASDAQ |
$14.00-$16.00 | $11.00 | $11.26 | 6.67 million | 7/30/2021 |
| BofA Securities, Stifel, Cantor, Canaccord Genuity | ||||||
Co-Manager(s): BTIG
| ||||||
| Health Care | ||||||
Filing(s): Filed 2021-07-09 Terms Added 2021-07-26 | ||||||
Rani Therapeutics Inc. Quote & Chart - Click for current quote - RANI
IPO Boutique aggregates information on public companies and private companies, such as "RANI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Rani Therapeutics Inc. (adapted from Rani Therapeutics Inc. prospectus):
They are a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics, which we believe will have the potential to transform medicine and improve patient outcomes
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics, which we believe will have the potential to transform medicine and improve patient outcomes
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "RANI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.